| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AKT signaling restrains tumor suppressive functions of FOXO transcription factors and GSK3 kinase in multiple myeloma
|
Bloedjes, Timon A.
|
|
|
4 |
17 |
p. 4151-4164
|
artikel
|
| 2 |
Allogeneic hematopoietic cell transplantation after prior targeted therapy for high-risk chronic lymphocytic leukemia
|
Kim, Haesook T.
|
|
|
4 |
17 |
p. 4113-4123
|
artikel
|
| 3 |
AMG 701 induces cytotoxicity of multiple myeloma cells and depletes plasma cells in cynomolgus monkeys
|
Goldstein, Rebecca L.
|
|
|
4 |
17 |
p. 4180-4194
|
artikel
|
| 4 |
Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734
|
Spriano, Filippo
|
|
|
4 |
17 |
p. 4124-4135
|
artikel
|
| 5 |
Charge-altering releasable transporters enable phenotypic manipulation of natural killer cells for cancer immunotherapy
|
Wilk, Aaron J.
|
|
|
4 |
17 |
p. 4244-4255
|
artikel
|
| 6 |
Cord blood CD8+ T-cell expansion following granulocyte transfusions eradicates refractory leukemia
|
Hiwarkar, Prashant
|
|
|
4 |
17 |
p. 4165-4174
|
artikel
|
| 7 |
Editorial Board
|
|
|
|
4 |
17 |
p. i
|
artikel
|
| 8 |
Effectiveness and safety of rivaroxaban compared with low-molecular-weight heparin in cancer-associated thromboembolism
|
Costa, Olivia S.
|
|
|
4 |
17 |
p. 4045-4051
|
artikel
|
| 9 |
Enhancing antitumor immunity through checkpoint blockade as a therapeutic strategy in T-cell lymphomas
|
Neuwelt, Alexander
|
|
|
4 |
17 |
p. 4256-4266
|
artikel
|
| 10 |
Integrin VLA-4 as a PET imaging biomarker of hyper-adhesion in transgenic sickle mice
|
Perkins, Lydia A.
|
|
|
4 |
17 |
p. 4102-4112
|
artikel
|
| 11 |
Pharmacometric modeling to explore 4F-PCC dosing strategies for VKA reversal in patients with INR below 2
|
Sarode, Ravi
|
|
|
4 |
17 |
p. 4208-4216
|
artikel
|
| 12 |
Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma
|
Kolstad, Arne
|
|
|
4 |
17 |
p. 4091-4101
|
artikel
|
| 13 |
Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia
|
Robak, Tadeusz
|
|
|
4 |
17 |
p. 4136-4146
|
artikel
|
| 14 |
PI3Kδ inhibition reshapes follicular lymphoma–immune microenvironment cross talk and unleashes the activity of venetoclax
|
Serrat, Neus
|
|
|
4 |
17 |
p. 4217-4231
|
artikel
|
| 15 |
Ponatinib coronary microangiopathy: novel bedside diagnostic approach and management with N-acetylcysteine
|
Wu, Melinda D.
|
|
|
4 |
17 |
p. 4083-4085
|
artikel
|
| 16 |
Recipient-specific T-cell repertoire reconstitution in the gut following murine hematopoietic cell transplant
|
Zheng, Pingping
|
|
|
4 |
17 |
p. 4232-4243
|
artikel
|
| 17 |
Sequential response-driven bortezomib-based therapy followed by autologous stem cell transplant in AL amyloidosis
|
Basset, Marco
|
|
|
4 |
17 |
p. 4175-4179
|
artikel
|
| 18 |
The critical role of CD4+ T cells in PD-1 blockade against MHC-II–expressing tumors such as classic Hodgkin lymphoma
|
Nagasaki, Joji
|
|
|
4 |
17 |
p. 4069-4082
|
artikel
|
| 19 |
The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALL
|
Bornhauser, Beat
|
|
|
4 |
17 |
p. 4052-4064
|
artikel
|
| 20 |
The immunomodulatory drugs lenalidomide and pomalidomide enhance the potency of AMG 701 in multiple myeloma preclinical models
|
Cho, Shih-Feng
|
|
|
4 |
17 |
p. 4195-4207
|
artikel
|
| 21 |
Variable CD34+ recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic
|
Purtill, Duncan
|
|
|
4 |
17 |
p. 4147-4150
|
artikel
|
| 22 |
Venous thromboembolism associated with CD19-directed CAR T-cell therapy in large B-cell lymphoma
|
Hashmi, Hamza
|
|
|
4 |
17 |
p. 4086-4090
|
artikel
|
| 23 |
von Willebrand factor variant D1472H has no effect in mice with humanized VWF-platelet interactions
|
Lohmeier, Hannah K.
|
|
|
4 |
17 |
p. 4065-4068
|
artikel
|
Tijdschrift beschrijving